Investigators Report New Renal, Mortality And Safety Data From NAPA Trial Of NATRECOR(R) (nesiritide) (Medical News Today)
Investigators today presented new renal, mortality and safety data from the NAPA(Nesiritide Administered Peri-Anesthesia in Patients Undergoing CardiacSurgery) trial, a Scios Inc.-sponsored study that evaluated NATRECOR(R)(nesiritide) in heart failure patients who required coronary artery bypassgraft (CABG) surgery using cardiopulmonary bypass. [click link for full article]

Genentech Receives Complete Response Letter From FDA For Avastin(R) In Metastatic Breast Cancer (Medical News Today)
Genentech, Inc. today announced that it received a Complete Response Letterfrom the U.S. Food and Drug Administration (FDA) for a supplementalBiologics License Application (sBLA) for Avastin(R) with chemotherapy infirst-line metastatic breast cancer. [click link for full article]

Aurobindo's citalopram oral solution gets US FDA approval (PharmaBiz)
Aurobindo Pharma Ltd has announced that its product citalopram oral solution 10mg/5ml has bagged US FDA approval. The company already has approval of citalopram tablets of 10,20, and 40mg strengths in tablet form.